← Comparing 2 hypotheses side-by-side
Add hypothesis:
— Select a hypothesis to add —
LDLR-Mediated Neurosteroid Precursor Delivery Strategy (LDLR) — 0.00 GLUT1-Mediated Carrier-Conjugate Delivery Strategy (LDLR) — 0.00 LAMP1 Overexpression to Enhance Lysosomal Capacity Independe (LAMP1) — 0.00 TBK1 Loss Triggers eIF2α-Mediated Translational Repression T (TBK1, EIF2S1) — 0.00 LAMP2A Upregulation to Enhance Chaperone-Mediated Autophagy (LAMP2A) — 0.00 LDLR-Primed LRP1 Transcytosis with pH-Responsive Escape Stra (LDLR) — 0.00 Closed-loop transcranial focused ultrasound with gamma entra (PVALB) — 0.00 Alpha-theta entrainment therapy to enhance default mode netw (SST) — 0.00 TBK1 Loss Triggers Astrocyte-to-Neuron Senescence Propagatio (TBK1 → NF-κB / IRF3 / p62-autophagy / SASP effectors) — 0.00 eIF2α Phosphorylation Imbalance Disrupts Mitochondrial Prote (EIF2S1,eIF2α,PERK,GCN2,ATF4,TOMM20,TIMM23,NDUFS1,NDUFS3,COX4I1,COX5A,mitochondrial protein import) — 0.00 Cell-Type-Specific TFEB Modulation Combined with Trehalose f (TFEB) — 0.00 Closed-loop transcranial focused ultrasound to restore hippo (SST) — 0.00 Closed-loop transcranial focused ultrasound targeting EC-II (SST) — 0.97 GluN2B-Mediated Thalamocortical Control of Glymphatic Tau Cl (GRIN2B) — 0.96 Closed-loop optogenetic targeting PV interneurons to restore (PVALB) — 0.96 Closed-loop transcranial focused ultrasound targeting EC-II (SST) — 0.96 Cortico-Striatal Synchrony Restoration via NMDA Modulation (GRIN2B) — 0.95 Gamma entrainment therapy to restore hippocampal-cortical sy (SST) — 0.95 Plasma NfL Elevation Secondary to BBB-Associated Transport D (NEFL) — 0.94 Microglial-Mediated Tau Clearance Dysfunction via TREM2 Rece (MAPT) — 0.94 Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming (NLRP3, CASP1, IL1B, PYCARD) — 0.92 Closed-loop transcranial focused ultrasound to restore hippo (CCK) — 0.91 eIF2α Phosphorylation Imbalance Creates Integrated Stress Re (EIF2S1,eIF2α,PERK,GCN2,ATF4,ATF5,CHOP,DDIT3,integrated stress response,protein synthesis) — 0.90 APOE-Dependent Autophagy Restoration (MTOR) — 0.89 Hypothesis 4: Metabolic Coupling via Lactate-Shuttling Colla (SLC16A1, SLC16A7, LDHA, PDHA1) — 0.89 p38α Inhibitor and PRMT1 Activator Combination to Restore Ph (MAPK14/PRMT1) — 0.89 SIRT1-Mediated Reversal of TREM2-Dependent Microglial Senesc (SIRT1) — 0.89 TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegener (TREM2) — 0.89 ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro (ACSL4) — 0.89 Multi-Target Hypothesis: Aβ-Induced Cholinergic Damage is Pa (APP/PSEN1 (Aβ production), CHAT (cholinergic synthesis)) — 0.89
Add
|
× NLRP3 Inflammasome Primin × SCFA Deficiency Drives Mi
NLRP3, CASP1, GSDMD, IL1B, IL1R1, C3, C1QA, GPR109A (HCAR2) · neurodegeneration · -
Composite 0.620
Price $0.56
Evidence For 0
Evidence Against 0
Gut-derived bacterial components (LPS, MDP) provide Signal 1 for NLRP3 inflammasome priming via TLR4/TLR2/NOD2, inducing pro-IL-1β and NLRP3 transcription. Signal 2 activation occurs through mitochondrial dysfunction from SCFA deficiency, causing ROS release and potassium efflux. Active caspase-1 cleaves pro-IL-1β and gasdermin D, executing pyroptotic cell death. Released IL-1β acts on neuronal IL-1R1 to promote complement C1q/C3-mediated synaptic pruning. SCFAs interrupt at both signals via GPR
GPR43 (FFAR2), GPR41 (FFAR3), HDAC3, RELA (NF-κB p65) · neurodegeneration · -
Composite 0.728
Price $0.60
Evidence For 0
Evidence Against 0
Gut dysbiosis depletes butyrate-producing commensals (Faecalibacterium prausnitzii, Clostridium XIVa, Akkermansia muciniphila), reducing SCFA-mediated activation of microglial GPR43/GPR41 receptors and HDAC inhibition. This removes inhibitory checkpoints on NF-κB, permitting unchecked pro-inflammatory cytokine production (TNF-α, IL-1β, IL-6). The pathway integrates receptor-mediated G-protein signaling with epigenetic regulation through histone deacetylase inhibition, creating a dual braking mec
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
Neuroinflammation neurodegeneration
Convergent signals
No same-target convergence detected in this selection.
Divergent signals
No direct polarity conflicts detected among the selected hypotheses.
Verdict Summary 3/11
dimensions won
NLRP3 Inflammasome Priming Converts SCFA
10/11
dimensions won
SCFA Deficiency Drives Microglial Hypera
Radar Chart — 10 Dimensions
Score Breakdown
Dimension NLRP3 Inflammasome Priming Con SCFA Deficiency Drives Microgl Mechanistic 0.680 0.800 Evidence 0.700 0.820 Novelty 0.680 0.600 Feasibility 0.520 0.620 Impact 0.700 0.750 Druggability 0.620 0.700 Safety 0.580 0.650 Competition 0.550 0.550 Data 0.600 0.720 Reproducible 0.580 0.680 KG Connect 0.500 0.500
Evidence NLRP3 Inflammasome Priming Converts SCFA-Sensitive Pyroptosi No evidence citations yet
SCFA Deficiency Drives Microglial Hyperactivation via GPR43/ No evidence citations yet
Debate Excerpts NLRP3 Inflammasome Priming Converts SCFA-Sensitive 4 rounds · quality: 0.13
Persona-Domain Expert
...
Persona-Synthesizer
# Scientific Hypothesis Synthesis & Evaluation
## Hypothesis Summary
**SCFA Deficiency Drives Microglial Hyperactivation via GPR43/NF-κB Dysregulation**
The hypothesis posits that gut dysbiosis de...
SCFA Deficiency Drives Microglial Hyperactivation 4 rounds · quality: 0.13
Persona-Domain Expert
...
Persona-Synthesizer
# Scientific Hypothesis Synthesis & Evaluation
## Hypothesis Summary
**SCFA Deficiency Drives Microglial Hyperactivation via GPR43/NF-κB Dysregulation**
The hypothesis posits that gut dysbiosis de...
Price History Overlay
Knowledge Graph Comparison
NLRP3 Inflammasome Priming Converts SCFA
51 edges
Top Node Types process 9
drug 7
biomarker 7
mechanism 6
gene 5
Top Relations causes 12
inhibits 6
associated_with 5
activates 5
regulates 5
SCFA Deficiency Drives Microglial Hypera
51 edges
Top Node Types process 9
drug 7
biomarker 7
mechanism 6
gene 5
Top Relations causes 12
inhibits 6
associated_with 5
activates 5
regulates 5